Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in applications of genome editing in therapeutics, increasing research activities in pharmaceutical and biotechnology sectors, and increasing demand for genetically edited crops.
The base editing market is segmented as below:
By Application
- Drug discovery and development
- Agriculture
- Veterinary
By Type
- DNA base editing
- RNA base editing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the base editing market covers the following areas:
- Base editing market sizing
- Base editing market forecast
- Base editing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global base editing market: Beam Therapeutics Inc., Bio Palette Co. Ltd., Cellectis SA, Creative Biogene, Danaher Corp., EdiGene Inc., ElevateBio, Genkore Co. Ltd., GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., KromaTiD Inc., Maravai LifeSciences Holdings Inc., Merck KGaA, Pairwise Plants Services, PerkinElmer Inc, ProQR Therapeutics NV, QI Biodesign Biotechnology Co. Ltd., Shape Therapeutics Inc., and Synthego Corp..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advancement in genome editing tools.'
According to the report, one of the major drivers for this market is the increase in applications of genome editing in therapeutics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Beam Therapeutics Inc.
- Bio Palette Co. Ltd.
- Cellectis SA
- Creative Biogene
- Danaher Corp.
- EdiGene Inc.
- ElevateBio
- Genkore Co. Ltd.
- GenScript Biotech Corp.
- Horizon Discovery Ltd.
- Intellia Therapeutics Inc.
- KromaTiD Inc.
- Maravai LifeSciences Holdings Inc.
- Merck KGaA
- Pairwise Plants Services
- PerkinElmer Inc
- ProQR Therapeutics NV
- QI Biodesign Biotechnology Co. Ltd.
- Shape Therapeutics Inc.
- Synthego Corp.